Obermatt

Pegavision

TAI:6491 · TW0006491004
Health Care Equipment & SuppliesSmall

360

78
EV / EBIT80
Price / Owner Earnings33
Owner Earnings Yield84
Dividend Yield85
Price/Sales34
EV / Gross Profit52
Price/Book55
Return on Capital83
Cash Return on Capital83
Return on Equity88
EBIT Margin88
Gross Profitability44
Cash Conversion8
Accruals5
Owner Earnings Margin92
Sales growth66
Profit Growth34
Long-Term EPS Growth25
Owner Earnings Growth69
Reinvestment4
Price momentum34
Debt load64
Refinancing6
Debt Payback100
Liquidity58
Analyst ratings62
Opinion Changes85
Price Target Upside34
Market mood33
Value Creation18/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Pegavision generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryTaiwan
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeTWSE
Founded2009
Employees57
ISINTW0006491004
Last UpdateApr 2, 2026
Index & Theme
OphthalmologySensorsDetectors, Sensors and MemsEyewearManufacturingMedical Device

Description

Pegavision Corporation (Pegavision) focuses on the manufacture and sale of medical devices, optical instruments, and precision instruments. The company specializes in producing high-quality contact lenses and related medical equipment for both domest…

Analysis

Middle-of-the-road

Pegavision Corporation is a middle-of-the-road business: neither the economics nor the price stand out from the peer group. One caution: reported profits have recently run ahead of actual cash, which we track closely.

The price is fair. You pay 21.3× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone.

The trajectory is moderate and the balance sheet is sturdy. The company scores 18/20 on our value-creation score: strong value creator.

What to watch: Some accounting patterns deserve a closer look. Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
34
2023202420252026

All-time high

98

Jan 2025

All-time low

10

Mar 2026

Average rank

62

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
34
27
31
34
Price/Earnings
79
74
62
47
Price/Book
55
37
24
22
Dividend Yield
85
82
70
68
Value (overall)
82
61
50
53

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Pegavision with its peers
Menicon
TYO:7780
51
CountryJapan
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Canon
TYO:7751
73
CountryJapan
IndustryTechnology Hardware, Storage & Peripherals
SizeLarge
Full Stock Analysis →
Suheung
KSC:008490
32
CountrySouth Korea
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Shinhung
KSC:004080
60
CountrySouth Korea
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
SD Biosensor
KSC:137310
15
CountrySouth Korea
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Huneed
KSC:005870
CountrySouth Korea
IndustryCommunications Equipment
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →